Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1518-2022Class II

The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use

Abbott Molecular, Inc. / initiated 2022-07-19 / Completed / root cause: manufacturing process

Abbott Molecular, Inc. began a recall of The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use on . FDA classified it as Class II and gives the reason as "Incorrect optical calibration". As of , the recall status on record is Completed, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1518-2022
Classification
Class II
Status
Completed
Initiated
Posted
Recalling firm
Abbott Molecular, Inc.
Product
The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use.
Product code
MZP Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
Reason for recall
Incorrect optical calibration
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
The recalling firm issued a letter dated 7/19/2022 via Abbott representative delivery on 7/19/2022 confirming the issue the customer had with their instrument. The letter also said the impacted ADU4 module was taken out of service on 1/25/2022 and was then replaced with a new module on 3/22/2022. The letter discussed the potential impact and the necessary actions to take which included completing and returning the Customer Reply Form and reviewing this information with laboratory personnel and retain the communication for future reference.
Quantity in commerce
1
Distribution
There was only foreign distribution to Italy.
Product codes and lots
Serial Number 00654

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1518-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1518-2022Class IICompletedVoluntary: Firm initiated